Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 100

3,450.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 5,405.00
  • 52 Week Low: 3,148.00
  • Currency: UK Pounds
  • Shares Issued: 108.39m
  • Volume: 989,410
  • Market Cap: £3,739.44m
  • RiskGrade: 121

Dechra acquires worldwide rights to canine lymphoma treatment

By Iain Gilbert

Date: Wednesday 12 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine lymphoma from Anivive Lifesciences.
Dechra said on Tuesday that under the terms of the agreement, it will acquire the global product rights and the first right of refusal for other species along with the trademark of Laverdia.

The FTSE 100-listed firm said the product, currently sold as Laverdia-CA1 in the USA, was a novel oral selective inhibitor of nuclear export drug and the first oral tablet for canine lymphoma.

Dechra will acquire the worldwide marketing rights, the rights to the intellectual property, the marketing authorisations, when granted, and associated regulatory documentation, supply contracts with third parties in relation to the raw material, and manufacture of the finished product.

The drug was conditionally approved by the FDA Center for Veterinary Medicine on 11 January 2021.

Chief executive Ian Page said: "We are delighted to acquire the worldwide rights to Laverdia. Its addition to our portfolio will expand Dechra into a new, niche therapy area, while also offering veterinarians and dog owners a simple to use, effective medication for lymphoma that extends the time a family has with their pet."

As of 0825 GMT, Dechra shares were up 2.98% at 4,428.0p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DPH Market Data

Currency UK Pounds
Share Price 3,450.00p
Change Today 50.00p
% Change 1.47 %
52 Week High 5,405.00
52 Week Low 3,148.00
Volume 989,410
Shares Issued 108.39m
Market Cap £3,739.44m
RiskGrade 121

DPH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.48% below the market average99.48% below the market average99.48% below the market average99.48% below the market average99.48% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
32.46% below the market average32.46% below the market average32.46% below the market average32.46% below the market average32.46% below the market average
26.98% above the sector average26.98% above the sector average26.98% above the sector average26.98% above the sector average26.98% above the sector average
Income
86.87% below the market average86.87% below the market average86.87% below the market average86.87% below the market average86.87% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Growth
63.64% above the market average63.64% above the market average63.64% above the market average63.64% above the market average63.64% above the market average
55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DPH Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 28-Oct-21
Paid 07-Apr-22 19-Nov-21
Amount 12.00p 29.39p

Trades for 20-May-2022

Time Volume / Share Price
16:45 650 @ 3,466.00p
16:45 650 @ 3,466.00p
16:44 214 @ 3,493.96p
16:35 124,861 @ 3,450.00p
16:29 131 @ 3,466.00p

DPH Key Personnel

CEO Ian Page
CFO Paul Sandland

Top of Page